Progressive Corporation
PGR
$220.28
+1.31%
Progressive Corporation is the largest publicly traded auto insurance underwriter in the United States, providing private and commercial auto coverage, specialty lines, and homeowners insurance through both independent agencies and direct-to-consumer channels, with nearly 27 million personal auto policies in force. The company is a structural disruptor in the Property & Casualty insurance industry, having built its competitive identity around a data-driven, direct-to-consumer model that undercuts traditional agency-based carriers on price while using telematics and sophisticated risk segmentation to maintain underwriting discipline. The current investor narrative centers on the durability of Progressive's underwriting machine and the growing contribution of investment income from its roughly $94 billion float, which is positioned to benefit from elevated interest rates, even as the stock has significantly underperformed the broader market over the past year. Debate among investors and analysts has intensified around whether the company's premium growth trajectory can be sustained as rate increases moderate, with recent commentary highlighting that underwriting is only half the story and that higher rates now power a meaningful portion of earnings.…
PGR
Progressive Corporation
$220.28
Related headlines
Investment Opinion: Should I buy PGR Today?
The synthesized recommendation is a Hold, with a neutral stance reflecting the balance between Progressive's strong fundamentals and its recent underperformance. The analyst consensus rating of 'hold' (mean 2.6) and average target price of $232.81 (7.1% upside) suggest that the stock is fairly valued at current levels. The core thesis is that Progressive remains a high-quality insurer with superior underwriting and profitability, but near-term catalysts are lacking, and earnings are expected to decline modestly.
Supporting evidence for the Hold rating includes: 1) Attractive valuation with a trailing PE of 11.81x, below the industry average of 15-18x, and a PEG ratio of 0.352; 2) Solid revenue growth of 7.37% year-over-year in Q2 2026, though moderating; 3) Exceptional profitability with a net margin of 14.02% and ROE of 37.29%, well above industry norms; 4) Strong free cash flow of $15.95 billion TTM, supporting a sustainable dividend yield of 2.15% with a low payout ratio of 25.39%. These metrics indicate a financially healthy company, but the forward PE higher than trailing PE signals expected earnings decline.
The biggest risks that could invalidate the thesis include: 1) A sharper-than-expected decline in underwriting profitability due to competitive pressures or adverse loss trends; 2) A significant drop in interest rates reducing investment income from the float; 3) Continued relative underperformance leading to multiple compression. The rating would upgrade to Buy if the stock price falls below $200 (approaching the analyst low target of $198) while fundamentals remain intact, or if revenue growth accelerates above 10% with margin expansion. It would downgrade to Sell if underwriting margins deteriorate significantly (e.g., combined ratio above 100%) or if ROE falls below 20%. Currently, the stock appears fairly valued relative to its history and peers, with a slight discount on PE but a premium on P/B, reflecting its superior profitability.
Sign up to view all
PGR 12-Month Price Forecast
Progressive presents a balanced risk-reward profile, with a high-quality business trading at a reasonable valuation but facing near-term headwinds from moderating growth and expected earnings decline. The stock's low beta and defensive characteristics make it suitable for risk-averse investors, but the lack of strong catalysts limits upside potential. The AI assessment is neutral with medium confidence, reflecting the tug-of-war between fundamental strength and relative underperformance. An upgrade to bullish would require evidence of accelerating premium growth and margin expansion, while a downgrade to bearish would be triggered by a significant deterioration in underwriting results or a sharp drop in interest rates.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Progressive Corporation's 12-month outlook, with a consensus price target around $232.81 and implied upside of +5.7% versus the current price.
Average Target
$232.81
0 analysts
Implied Upside
+5.7%
vs. current price
Analyst Count
—
covering this stock
Price Range
$198 - $314
Analyst target range
Progressive is covered by 21 analysts, with a consensus recommendation of "hold" and a recommendation mean of 2.6 on a scale where 1 is a strong buy and 5 is a strong sell, indicating a neutral to slightly cautious sentiment. The average target price of $232.81 implies an upside of approximately 7.1% from the current price of $217.43, suggesting that analysts see modest appreciation potential but not a compelling value opportunity at current levels. The consensus leans neutral rather than bullish, reflecting the tension between the company's strong fundamentals and the stock's recent underperformance, with the hold rating suggesting that analysts believe the stock is fairly valued after its recent recovery. The target price range spans from a low of $198.00 to a high of $314.00, a spread of $116.00 or approximately 58.6% of the average target, which signals significant disagreement among analysts about the company's prospects. The high target of $314.00 implies a bullish scenario where Progressive benefits from accelerating premium growth, expanding investment income from its float, and multiple expansion as the market recognizes the company's superior underwriting capabilities, while the low target of $198.00 prices in margin compression from competitive pressures, potential reserve strengthening, or a broader economic downturn that reduces insurable exposure. Recent institutional ratings show a mix of actions, with Keefe, Bruyette & Woods upgrading to Outperform from Market Perform on August 20, 2026, while Morgan Stanley upgraded to Equal Weight from Underweight on July 24, 2026, suggesting that some analysts are becoming more constructive on the stock after its decline. However, Wells Fargo maintains an Underweight rating as of August 20, 2026, and several firms including Mizuho, UBS, Cantor Fitzgerald, and JP Morgan hold Neutral ratings, indicating that the bearish case remains credible. The wide target spread and the predominance of neutral ratings suggest that while the stock may have bottomed, there is no strong consensus that it is poised for significant outperformance in the near term.
Bulls vs Bears: PGR Investment Factors
The bull case for Progressive rests on its exceptional profitability (ROE of 37.29%), attractive valuation (PE of 11.81x), and robust cash flow generation ($15.95B TTM), which collectively suggest a high-quality company trading at a discount. However, the bear case highlights persistent underperformance (-10.21% over 1 year), expected earnings decline (forward PE > trailing PE), and moderating premium growth (7.37% YoY), which could limit upside. Currently, the bear evidence appears slightly stronger given the stock's relative weakness and neutral analyst sentiment, but the fundamental strength provides a solid foundation. The most critical tension is whether Progressive can sustain its underwriting profitability and premium growth as rate increases moderate; if it can, the stock is undervalued, but if growth stalls, the premium valuation may compress.
Bullish
- Exceptional ROE of 37.29%: Progressive's return on equity of 37.29% is more than double the typical P&C insurance industry range of 10-15%, reflecting a durable underwriting moat and efficient capital deployment. This superior profitability supports a premium valuation and provides a buffer against cyclical downturns.
- Attractive valuation at 11.81x trailing PE: The stock trades at a trailing PE of 11.81x, a 25-35% discount to the industry average of 15-18x for large-cap P&C insurers. With a PEG ratio of 0.352, the valuation appears inexpensive relative to expected earnings growth, suggesting potential for multiple expansion.
- Robust free cash flow of $15.95B TTM: Progressive generated $15.95 billion in trailing twelve-month free cash flow, with $3.47 billion in Q2 2026 alone, demonstrating strong cash generation to fund growth, dividends, and buybacks. This financial flexibility supports shareholder returns and strategic investments.
- Conservative balance sheet with low leverage: The debt-to-equity ratio of 0.227 is well below the industry average, and interest coverage of 47.83x indicates ample capacity to service obligations. This low leverage reduces financial risk and provides resilience in economic downturns.
Bearish
- Significant underperformance vs. market: PGR has declined 10.21% over the past year while SPY gained 16.0%, resulting in a relative strength of -26.21 percentage points. This persistent underperformance may reflect structural challenges or a rotation away from defensive sectors.
- Earnings expected to decline in coming year: The forward PE of 13.29x is higher than the trailing PE of 11.81x, implying that the market expects earnings to decline. Analyst consensus EPS of $16.05 is below trailing EPS of $18.42, suggesting a normalization of underwriting profitability after exceptional results.
- Premium growth moderating to 7.37%: Q2 2026 revenue growth of 7.37% year-over-year is healthy but represents a deceleration from prior periods of explosive growth. As rate increases moderate, sustaining premium growth becomes more challenging, potentially pressuring the valuation multiple.
- Neutral analyst consensus with hold rating: The consensus recommendation is 'hold' with a mean of 2.6 out of 5, and several firms maintain Underweight or Neutral ratings. This lack of strong bullish conviction suggests limited near-term catalysts for outperformance.
PGR Technical Analysis
Progressive is in a recovery phase within a broader range-bound consolidation, with the stock trading at $217.43 as of October 9, 2026, representing a decline of 10.21% over the past year. The current price sits at approximately 51.7% of its 52-week range, calculated from a low of $189.20 to a high of $243.81, positioning it in the middle of its annual range rather than at either extreme. This mid-range positioning suggests neither momentum-driven overextension nor deep-value territory, but rather a stock that has stabilized after a significant drawdown, with a maximum drawdown of 23.54% reflecting the severity of the prior selloff. Recent momentum has turned modestly positive, with a 1-month gain of 0.90% and a 6-month gain of 12.00%, though the 3-month change of -5.76% indicates a mid-year pullback that interrupted the recovery. The 1-month trend diverges from the 1-year decline, signaling potential mean reversion or a temporary stabilization, but the 3-month negative reading suggests the recovery is not yet firmly established. Relative strength metrics reinforce the underperformance narrative, with PGR lagging SPY by 26.21 percentage points over 1 year and by 8.89 percentage points over 3 months, though the 1-month relative strength of -1.22% shows the gap narrowing slightly. Key technical support is anchored at the 52-week low of $189.20, while resistance sits at the 52-week high of $243.81; a breakout above resistance would signal a full trend reversal and renewed institutional accumulation, while a breakdown below support would confirm the bearish longer-term trend and likely trigger further selling pressure. The stock's beta of 0.235 is remarkably low, indicating that PGR is approximately 76.5% less volatile than the broader market, which has important implications for position sizing and risk management, as the stock offers defensive characteristics but may lag in strong bull markets.
Beta
0.23
0.23x market volatility
Max Drawdown
-23.5%
Largest decline past year
52-Week Range
$189-$241
Price range past year
Annual Return
-8.2%
Cumulative gain past year
| Period | PGR Return | S&P 500 |
|---|---|---|
| 1m | +1.2% | +1.8% |
| 3m | -2.8% | +3.5% |
| 6m | +9.5% | +11.2% |
| 1y | -8.2% | +19.1% |
| ytd | +3.8% | +14.1% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
PGR Fundamental Analysis
Progressive's revenue trajectory remains solidly positive, with Q2 2026 revenue of $23.62 billion representing 7.37% year-over-year growth from Q2 2025's $21.99 billion, continuing a multi-quarter expansion that has seen revenue rise from $20.40 billion in Q1 2025 to $22.18 billion in Q1 2026 and $23.62 billion in Q2 2026. The Personal Lines segment dominates the business with $18.66 billion in revenue, while Commercial Lines contributes $2.60 billion, reflecting the company's concentrated bet on personal auto insurance as its core growth engine. The sequential revenue progression from $22.74 billion in Q4 2025 to $22.18 billion in Q1 2026 and then to $23.62 billion in Q2 2026 demonstrates resilience despite seasonal fluctuations, though the growth rate has moderated from the explosive pace seen in prior years when the company was aggressively taking market share through rate increases. The investment case hinges on whether Progressive can sustain mid-single-digit premium growth while maintaining underwriting discipline, as the revenue growth rate of 7.37% is healthy but not exceptional for a company trading at a premium valuation. Profitability remains robust, with Q2 2026 net income of $3.31 billion and a net margin of 14.02%, up from 12.71% in Q1 2026 and 12.98% in Q4 2025, demonstrating consistent margin expansion. The gross margin of 25.15% in Q2 2026, while lower than Q1 2026's 37.66%, is within the normal quarterly fluctuation range for insurance underwriting and reflects the seasonal catastrophe loss patterns typical of the industry. Operating margin stands at 17.82% for Q2 2026, with EBITDA of $4.38 billion and an EBITDA ratio of 18.53%, indicating that the company converts a substantial portion of revenue into operating profit. The company's ROE of 37.29% is exceptionally strong for the insurance sector, where returns in the mid-teens are more typical, reflecting Progressive's superior underwriting profitability and efficient capital deployment. The balance sheet is conservatively managed with a debt-to-equity ratio of just 0.227, well below the industry average, and interest coverage of 47.83x in Q2 2026, indicating ample capacity to service obligations. Free cash flow remains robust at $15.95 billion on a trailing twelve-month basis, with Q2 2026 free cash flow of $3.47 billion and operating cash flow of $3.61 billion, demonstrating the company's ability to fund growth internally without relying on external financing. The current ratio of 0.586 appears low but is typical for insurance companies where policy liabilities are classified as current; the quick ratio of 1.60 from historical data provides a more accurate liquidity picture. The company returned capital to shareholders through $614 million in stock repurchases and $58 million in dividends in Q2 2026, while maintaining a strong cash position and investment portfolio.
Quarterly Revenue
$23.6B
2026-06
Revenue YoY Growth
+7.4%
YoY Comparison
Gross Margin
25.1%
Latest Quarter
Free Cash Flow
$16.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is PGR Overvalued?
Since Progressive reported positive net income of $3.31 billion in Q2 2026, the PE ratio is the appropriate primary valuation metric, and the stock trades at a trailing PE of 11.81x versus a forward PE of 13.29x. The forward PE being higher than the trailing PE implies that the market expects earnings to decline modestly in the coming year, which is consistent with the analyst consensus EPS estimate of $16.05 against trailing EPS of approximately $18.42, suggesting that the market is pricing in some normalization of underwriting profitability after a period of exceptional results. The PEG ratio of 0.352 is notably low, indicating that the stock is inexpensive relative to its earnings growth rate, though this metric should be interpreted cautiously given the cyclical nature of insurance earnings. Comparing Progressive's valuation to the broader Financial Services sector, the stock's PE of 11.81x is below the typical industry average of 15-18x for large-cap P&C insurers, representing a discount of approximately 25-35%, while the price-to-book ratio of 4.40x is at a premium to the sector average of 1.5-2.0x, reflecting Progressive's superior ROE of 37.29% versus the industry's typical 10-15%. The price-to-sales ratio of 1.52x and EV/EBITDA of 9.47x are both reasonable for a company with Progressive's growth and profitability profile, and the dividend yield of 2.15% with a payout ratio of 25.39% indicates a sustainable and growing dividend. Historically, Progressive's PE ratio has ranged from a low of 8.48x in Q2 2026 to a high of 138.35x in Q3 2022, with the current 11.81x sitting in the lower quartile of its 5-year range, suggesting the stock is near the bottom of its historical valuation band. The PS ratio of 1.52x is also near the low end of its historical range of 4.76x to 8.13x seen over the past several years, though the dramatic decline reflects changes in the share count and revenue base rather than pure multiple compression. The current valuation suggests that the market is pricing in pessimistic expectations for Progressive's earnings power, potentially creating a value opportunity if the company can sustain its underwriting profitability and benefit from elevated investment income.
PE
11.8x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 8x~23x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
9.5x
Enterprise Value Multiple
Investment Risk Disclosure
Progressive's financial risks are relatively contained but not negligible. The debt-to-equity ratio of 0.227 is conservative, and interest coverage of 47.83x is robust, indicating low financial leverage risk. However, the current ratio of 0.586 appears low, though this is typical for insurers due to policy liabilities classified as current; the quick ratio of 1.60 from historical data provides better liquidity insight. The primary financial risk stems from potential margin compression: the gross margin declined to 25.15% in Q2 2026 from 37.66% in Q1 2026, reflecting seasonal catastrophe losses and competitive pricing pressure. Additionally, the company's revenue is heavily concentrated in personal auto insurance ($18.66 billion of $23.62 billion in Q2 2026 revenue), making it vulnerable to regulatory changes or shifts in driving behavior that could impact claims frequency and severity.
Market and competitive risks are significant given Progressive's premium valuation relative to peers on some metrics. While the PE of 11.81x is below the industry average, the price-to-book ratio of 4.40x is at a premium to the sector average of 1.5-2.0x, justified by the superior ROE of 37.29%. If ROE normalizes toward industry levels, the stock could face multiple compression. The low beta of 0.235 indicates defensive characteristics, but also means the stock may lag in bull markets, as evidenced by the 26.21 percentage point underperformance versus SPY over the past year. Competitive pressures from other insurers like Berkshire Hathaway's GEICO and Allstate could erode Progressive's market share, especially if they match its data-driven pricing strategies. Recent news highlights that higher interest rates power a meaningful portion of earnings through the $94 billion float, but if rates decline, investment income could fall, impacting overall profitability.
The worst-case scenario for Progressive would involve a combination of factors: a sharp increase in auto accident frequency and severity leading to underwriting losses, a decline in interest rates reducing investment income, and intensified competition forcing price cuts. In such a scenario, the stock could retest its 52-week low of $189.20, representing a downside of approximately 13% from the current price of $217.43. The analyst low target of $198.00 implies a more modest 8.9% decline, but if earnings disappoint significantly, the stock could fall further. The maximum drawdown over the past year was 23.54%, indicating that a decline to around $166 would be within historical volatility. Investors could lose 13-24% in a severe adverse scenario, with the 52-week low serving as a key support level.
FAQ
The key risks include: 1) Financial risk: margin compression, as gross margin fell to 25.15% in Q2 2026 from 37.66% in Q1 2026, and revenue is concentrated in personal auto (79% of Q2 revenue). 2) Competitive risk: intensifying competition from GEICO and Allstate could erode market share and pricing power. 3) Macro risk: a decline in interest rates would reduce investment income from the $94 billion float, which currently benefits from elevated rates. 4) Company-specific risk: potential reserve strengthening or adverse loss trends could lead to earnings misses. The most severe risk is a combination of margin compression and lower investment income, which could drive the stock to the 52-week low of $189.20.
The 12-month forecast includes three scenarios: Bull case (25% probability) with a target range of $280-$314, driven by accelerating premium growth and multiple expansion; Base case (55% probability) with a target range of $225-$240, assuming stable underwriting and mid-single-digit growth; Bear case (20% probability) with a target range of $189-$198, reflecting margin compression and lower investment income. The base case is most likely, anchored by the analyst average target of $232.81. The key assumption is that Progressive maintains a combined ratio in the mid-90s and benefits from stable interest rates.
PGR appears fairly valued to slightly undervalued on an earnings basis but premium on a book value basis. The trailing PE of 11.81x is below the industry average of 15-18x, suggesting a discount of 25-35%. However, the price-to-book ratio of 4.40x is well above the sector average of 1.5-2.0x, justified by the exceptional ROE of 37.29%. The PEG ratio of 0.352 indicates undervaluation relative to growth, but the cyclical nature of insurance earnings warrants caution. The market is pricing in a modest earnings decline, as reflected in the forward PE exceeding the trailing PE. Overall, the stock is not overvalued, but it is not a deep-value opportunity either.
From a risk/reward perspective, PGR is a Hold rather than a strong Buy at current levels. The stock trades at $217.43, with a trailing PE of 11.81x and a PEG ratio of 0.352, which appears attractive relative to the industry average PE of 15-18x. However, the analyst consensus target of $232.81 implies only 7.1% upside, and the forward PE of 13.29x suggests expected earnings decline. The biggest downside risk is a retest of the 52-week low of $189.20, representing a 13% decline. For long-term investors with a defensive tilt, PGR could be a good buy on dips below $200, but for those seeking high growth, it may underperform.
PGR is more suitable for long-term investment due to its low beta of 0.235, defensive characteristics, and consistent dividend growth. The stock's volatility is significantly lower than the market, making it less appealing for short-term trading. The dividend yield of 2.15% with a payout ratio of 25.39% provides income and suggests room for future increases. Earnings visibility is moderate, with quarterly fluctuations due to catastrophe losses. A minimum holding period of 2-3 years is recommended to ride out insurance cycles and benefit from compounding of dividends and buybacks. Short-term traders may find limited opportunities given the stock's low beta and range-bound trading.